Industry litigation – Page 5
-
BusinessMonsanto agrees $12 million settlement for Hawaii pesticide violations
Bayer-owned firm admits charges relating to use and storage of pesticides on its research farms
-
BusinessPharmaceuticals roundup 2021
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
-
OpinionA clouded view of industry emissions
Standards and auditing are sorely needed if emissions targets are to be upheld
-
BusinessPfizer sues former employee for alleged trade secret theft
Chun Xiao Li downloaded thousands of confidential documents before resigning
-
BusinessNew J&J subsidiary to absorb talc lawsuit liabilities
Firm aims to use bankruptcy protection and a $2bn trust to resolve thousands of cancer claims
-
BusinessBees face a barrage of chemical and environmental burdens
Better understanding of the combined effects of multiple stress factors could help reduce pollinator decline
-
BusinessSecond Daikin-America employee dies from chemical exposure
Chemical that killed two workers and hospitalised a third at a US fluorochemicals plant remains unidentified
-
BusinessUS judge accepts Purdue’s opioid bankruptcy settlement plan
Deal releases $4.3bn to combat addiction, but protects Sackler family from litigation
-
BusinessUS bans chlorpyrifos on all food crops
Environmental agency removes remaining exceptions for agricultural use of controversial insecticide
-
OpinionThe price of failure
Drug market structures and high R&D failure rates can tempt companies into bad pricing behaviour
-
BusinessBudget cuts at UK medicines regulator raise eyebrows
MHRA to cut 300 jobs amid financial pressures arising from Brexit
-
BusinessDeveloping countries sidelined in Covid-19 vaccine scramble
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
-
BusinessIndustry tightens emissions reduction targets
As COP26 approaches, many firms are announcing ambitious climate goals. But are they achievable?
-
BusinessUS judge rules against GSK in trade secrets dispute
Firm will not receive compensation for claimed loses of over $1bn from theft of confidential information by two former scientists
-
BusinessUS supreme court will not hear J&J talc appeal
Decision means J&J must pay $2.1 billion previously awarded to 22 women who say talc caused their ovarian cancer
-
BusinessUS supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
BusinessWhat might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
BusinessCoca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
OpinionA powerful blow against misconduct
Supporting whistleblowers is vital for detecting and preventing bad behaviour
-
OpinionRewards based on priority drive unnecessary competition
The story of Crispr illustrates how a focus on patents and publications can cause good people to act in unsavoury ways